Becker's Healthcare March 21, 2023
In advance of the ending of the COVID-19 public health emergency on May 11, the FDA will end some of the 72 pandemic-related guidance policies and keep some in place for an additional 180 days after the PHE ends, according to a notice in the March 13 Federal Register.
Further, the FDA said, 24 policies are expected to remain in place for the long term — with revisions that will be considered by FDA leaders during the 180-day period following the end of the PHE.
“Circumstances have changed since 2020 when FDA first began issuing guidances to support COVID-19 response efforts. For example, several COVID-19 guidances were developed to
help address supply chain disruptions. In several instances, supply chains...
Today's Sponsors
Today's Sponsor